To our knowledge, this is the first study assessing CAR and ABCD2 clinical risk scores for stroke in stratifying the underlying disease pathophysiology of patients with symptomatic carotid atherosclerosis. This evidence concerns the gene ABCD2 and carotid atherosclerosis.